Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00873054 · ClinicalTrials.gov registry record
Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy
A clinical trial, sponsored by CAMC Health System.
- Completed
- Registry status
- 32
- Enrollment target
NCT00873054: Completed study, sponsored by CAMC Health System.
NCT00873054 is a clinical trial that has completed, run by CAMC Health System. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00873054 has completed, sponsored by CAMC Health System.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The investigators main hypothesis is that the stone free rate will be much higher (95%) in patients treated with PCNL than patients treated with ESWL where stone free rate is (60%) to determine which treatment is safe and prevent less stone recurrence.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-01 |
What the finished NCT00873054 record still lists
NCT00873054 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00873054 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00873054 about?
NCT00873054 is a clinical study titled "Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy". The investigators main hypothesis is that the stone free rate will be much higher (95%) in patients treated with PCNL than patients treated with ESWL where stone free rate is (60%) to determine which treatment is safe and prevent less stone recurrence.
What is the current status of trial NCT00873054?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2008-10. Estimated completion is 2011-01.
Who is sponsoring clinical trial NCT00873054?
This trial is sponsored by CAMC Health System, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia